+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Neurological Biomarkers Market by Biomarker Type (Cellular, Genetic, Imaging), Technology Platform (Enzyme-Linked Immunosorbent Assay, Imaging Techniques, Mass Spectrometry), Application, End User - Global Forecast 2025-2030- Product Image
Neurological Biomarkers Market by Biomarker Type (Cellular, Genetic, Imaging), Technology Platform (Enzyme-Linked Immunosorbent Assay, Imaging Techniques, Mass Spectrometry), Application, End User - Global Forecast 2025-2030- Product Image
Sale

Neurological Biomarkers Market by Biomarker Type (Cellular, Genetic, Imaging), Technology Platform (Enzyme-Linked Immunosorbent Assay, Imaging Techniques, Mass Spectrometry), Application, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 180 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5454976
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Neurological biomarkers are increasingly recognized as critical assets for advancing diagnostics, treatment monitoring, and clinical research in neurological disorders. As the neurological biomarkers market evolves, leadership teams are seeking actionable intelligence to inform strategic investments, optimize research and development, and sustain competitive advantages.

Market Snapshot: Neurological Biomarkers Market Growth and Momentum

The Neurological Biomarkers Market grew from USD 10.24 billion in 2024 to USD 11.74 billion in 2025. It is expected to continue growing at a CAGR of 14.09%, reaching USD 22.59 billion by 2030. Ongoing innovation in molecular biology, high-resolution imaging, and artificial intelligence has unlocked new pathways for biomarker discovery and application. Regulatory harmonization and industry partnerships are shaping a market landscape that is resilient against supply disruptions and primed for continued expansion through advanced diagnostics and precision medicine solutions.

Scope & Segmentation: Comprehensive Outlook for Decision-Makers

  • Biomarker Types: Cellular, Genetic, Imaging, Metabolite, Protein.
  • Technology Platforms: Enzyme-Linked Immunosorbent Assay, Imaging Techniques (Computed Tomography, Functional Near-Infrared Spectroscopy, Magnetic Resonance Imaging, Positron Emission Tomography), Mass Spectrometry, Next-Generation Sequencing (RNA Sequencing, Targeted Resequencing, Whole Genome Sequencing), Polymerase Chain Reaction.
  • Applications: Diagnostics, Drug Development, Monitoring, Prognostics, Research.
  • End Users: Contract Research Organizations, Diagnostic Laboratories, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Research Institutes.
  • Geographic Regions: Americas (including United States - California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio; Canada; Mexico; Brazil; Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan).
  • Leading Companies: Danaher Corporation, Thermo Fisher Scientific Inc., Roche Holding AG, Siemens Healthineers AG, Abbott Laboratories, Bio-Rad Laboratories, Inc., PerkinElmer, Inc., Quanterix Corporation, Meso Scale Diagnostics, LLC, Fujirebio Diagnostics, Inc.

Key Takeaways: Strategic Insights for Senior Leaders

  • Neurological biomarkers are reshaping diagnostic timelines, enabling earlier detection and intervention in neurodegenerative and mood disorders.
  • High-throughput sequencing and mass spectrometry technologies are broadening the range of discoverable biomarkers, increasing market value for precision analytics platforms.
  • Regulatory advances are fostering greater global harmonization, supporting streamlined validation and market entry for novel diagnostic tools.
  • Strategic alliances, including mergers, co-development initiatives, and data-sharing consortia, are key to pipeline expansion and accelerated product commercialization.
  • Digital biomarkers and AI-driven data analytics are enhancing longitudinal disease monitoring and personalized therapeutic strategies.
  • Regional differences in funding, infrastructure, and regulatory frameworks are shaping adoption patterns and presenting unique growth opportunities and challenges.

Tariff Impact: Navigating Supply Chain and Investment Pressures

Newly enacted United States tariff policies in 2025 have increased costs and delivery times for critical reagents and imaging hardware within neurological biomarker supply chains. Stakeholders are responding by diversifying supplier networks, renegotiating contracts, and strengthening local manufacturing partnerships. Sustained, adaptive planning is essential to maintain project continuity and mitigate future risks attributable to global trade dynamics.

Methodology & Data Sources

This report synthesizes data from rigorous secondary research, patent and regulatory filings, and targeted interviews with thought leaders in neuroscience and diagnostics. Data triangulation and iterative model reviews ensure high reliability and actionable insights grounded in both quantitative and expert qualitative perspectives.

Why This Report Matters

  • Senior leaders gain targeted, segment-specific intelligence to inform investment, partnership, and product strategy in the neurological biomarkers sector.
  • The report clarifies technology and region-driven demand drivers to support effective market entry or expansion decisions.
  • Insights into regulatory and policy shifts help organizations proactively manage compliance and operational risks.

Conclusion

Increased innovation and regulatory agility are fueling growth and diversification across the neurological biomarkers landscape. Informed strategy, supply chain resilience, and collaborative ecosystems will determine long-term leadership in this evolving market.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of plasma phosphorylated tau 217 assays for early Alzheimer’s detection in multicenter clinical studies
5.2. Emergence of ultrasensitive single-molecule array technology for quantifying neurofilament light chain levels in blood samples
5.3. Development of multiplex cerebrospinal fluid biomarker panels combining amyloid beta and tau isoforms for differential dementia diagnosis
5.4. Adoption of digital immunoassay platforms enabling remote monitoring of biomarker fluctuations in Parkinson’s disease patients
5.5. Expansion of artificial intelligence algorithms to interpret complex biomarker data patterns in early detection of neurodegenerative disorders
5.6. Advancements in blood-based inflammatory biomarker assays to track microglial activation in multiple sclerosis therapeutic trials
5.7. Growth of regulatory support pathways for novel neurological biomarker clearance in drug development and personalized medicine applications
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Neurological Biomarkers Market, by Biomarker Type
8.1. Introduction
8.2. Cellular
8.3. Genetic
8.4. Imaging
8.5. Metabolite
8.6. Protein
9. Neurological Biomarkers Market, by Technology Platform
9.1. Introduction
9.2. Enzyme-Linked Immunosorbent Assay
9.3. Imaging Techniques
9.3.1. Computed Tomography
9.3.2. Functional Near-Infrared Spectroscopy
9.3.3. Magnetic Resonance Imaging
9.3.4. Positron Emission Tomography
9.4. Mass Spectrometry
9.5. Next-Generation Sequencing
9.5.1. RNA Sequencing
9.5.2. Targeted Resequencing
9.5.3. Whole Genome Sequencing
9.6. Polymerase Chain Reaction
10. Neurological Biomarkers Market, by Application
10.1. Introduction
10.2. Diagnostics
10.3. Drug Development
10.4. Monitoring
10.5. Prognostics
10.6. Research
11. Neurological Biomarkers Market, by End User
11.1. Introduction
11.2. Contract Research Organizations
11.3. Diagnostic Laboratories
11.4. Hospitals & Clinics
11.5. Pharmaceutical & Biotechnology Companies
11.6. Research Institutes
12. Americas Neurological Biomarkers Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Neurological Biomarkers Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Neurological Biomarkers Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Danaher Corporation
15.3.2. Thermo Fisher Scientific Inc.
15.3.3. Roche Holding AG
15.3.4. Siemens Healthineers AG
15.3.5. Abbott Laboratories
15.3.6. Bio-Rad Laboratories, Inc.
15.3.7. PerkinElmer, Inc.
15.3.8. Quanterix Corporation
15.3.9. Meso Scale Diagnostics, LLC
15.3.10. Fujirebio Diagnostics, Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. NEUROLOGICAL BIOMARKERS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2024 VS 2030 (%)
FIGURE 8. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS NEUROLOGICAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS NEUROLOGICAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES NEUROLOGICAL BIOMARKERS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES NEUROLOGICAL BIOMARKERS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC NEUROLOGICAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC NEUROLOGICAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. NEUROLOGICAL BIOMARKERS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. NEUROLOGICAL BIOMARKERS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. NEUROLOGICAL BIOMARKERS MARKET: RESEARCHAI
FIGURE 24. NEUROLOGICAL BIOMARKERS MARKET: RESEARCHSTATISTICS
FIGURE 25. NEUROLOGICAL BIOMARKERS MARKET: RESEARCHCONTACTS
FIGURE 26. NEUROLOGICAL BIOMARKERS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. NEUROLOGICAL BIOMARKERS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY CELLULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY CELLULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY GENETIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY GENETIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY METABOLITE, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY METABOLITE, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY PROTEIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY PROTEIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY FUNCTIONAL NEAR-INFRARED SPECTROSCOPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY FUNCTIONAL NEAR-INFRARED SPECTROSCOPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY RNA SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY RNA SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TARGETED RESEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TARGETED RESEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY MONITORING, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY MONITORING, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY PROGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY PROGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS NEUROLOGICAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS NEUROLOGICAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES NEUROLOGICAL BIOMARKERS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES NEUROLOGICAL BIOMARKERS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 103. CANADA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 104. CANADA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 105. CANADA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 106. CANADA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 107. CANADA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2024 (USD MILLION)
TABLE 108. CANADA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2025-2030 (USD MILLION)
TABLE 109. CANADA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 110. CANADA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 111. CANADA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 112. CANADA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 113. CANADA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 114. CANADA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 115. MEXICO NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 116. MEXICO NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 117. MEXICO NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 118. MEXICO NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 119. MEXICO NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2024 (USD MILLION)
TABLE 120. MEXICO NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2025-2030 (USD MILLION)
TABLE 121. MEXICO NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 122. MEXICO NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 123. MEXICO NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 124. MEXICO NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 125. MEXICO NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 126. MEXICO NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 127. BRAZIL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 128. BRAZIL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 129. BRAZIL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 130. BRAZIL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 131. BRAZIL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2024 (USD MILLION)
TABLE 132. BRAZIL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2025-2030 (USD MILLION)
TABLE 133. BRAZIL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 134. BRAZIL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 135. BRAZIL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 136. BRAZIL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 137. BRAZIL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 138. BRAZIL NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 139. ARGENTINA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 140. ARGENTINA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 141. ARGENTINA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 142. ARGENTINA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 143. ARGENTINA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2024 (USD MILLION)
TABLE 144. ARGENTINA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2025-2030 (USD MILLION)
TABLE 145. ARGENTINA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 146. ARGENTINA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 147. ARGENTINA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 148. ARGENTINA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 149. ARGENTINA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 150. ARGENTINA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2024 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2025-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 165. UNITED KINGDOM NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 166. UNITED KINGDOM NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 167. UNITED KINGDOM NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 168. UNITED KINGDOM NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 169. UNITED KINGDOM NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2024 (USD MILLION)
TABLE 170. UNITED KINGDOM NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2025-2030 (USD MILLION)
TABLE 171. UNITED KINGDOM NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 172. UNITED KINGDOM NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 173. UNITED KINGDOM NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 174. UNITED KINGDOM NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 175. UNITED KINGDOM NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 176. UNITED KINGDOM NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 177. GERMANY NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 178. GERMANY NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 179. GERMANY NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 180. GERMANY NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 181. GERMANY NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2024 (USD MILLION)
TABLE 182. GERMANY NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2025-2030 (USD MILLION)
TABLE 183. GERMANY NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 184. GERMANY NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 185. GERMANY NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 186. GERMANY NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 187. GERMANY NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 188. GERMANY NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 189. FRANCE NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 190. FRANCE NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 191. FRANCE NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 192. FRANCE NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 193. FRANCE NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2024 (USD MILLION)
TABLE 194. FRANCE NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2025-2030 (USD MILLION)
TABLE 195. FRANCE NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 196. FRANCE NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 197. FRANCE NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 198. FRANCE NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 199. FRANCE NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 200. FRANCE NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 201. RUSSIA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 202. RUSSIA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 203. RUSSIA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 204. RUSSIA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 205. RUSSIA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2024 (USD MILLION)
TABLE 206. RUSSIA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2025-2030 (USD MILLION)
TABLE 207. RUSSIA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 208. RUSSIA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 209. RUSSIA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 210. RUSSIA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 211. RUSSIA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 212. RUSSIA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 213. ITALY NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 214. ITALY NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 215. ITALY NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 216. ITALY NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 217. ITALY NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2024 (USD MILLION)
TABLE 218. ITALY NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2025-2030 (USD MILLION)
TABLE 219. ITALY NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 220. ITALY NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 221. ITALY NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 222. ITALY NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 223. ITALY NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 224. ITALY NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 225. SPAIN NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 226. SPAIN NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 227. SPAIN NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 228. SPAIN NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 229. SPAIN NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2024 (USD MILLION)
TABLE 230. SPAIN NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2025-2030 (USD MILLION)
TABLE 231. SPAIN NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 232. SPAIN NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 233. SPAIN NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 234. SPAIN NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 235. SPAIN NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 236. SPAIN NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 237. UNITED ARAB EMIRATES NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 238. UNITED ARAB EMIRATES NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 239. UNITED ARAB EMIRATES NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 240. UNITED ARAB EMIRATES NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 241. UNITED ARAB EMIRATES NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2024 (USD MILLION)
TABLE 242. UNITED ARAB EMIRATES NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2025-2030 (USD MILLION)
TABLE 243. UNITED ARAB EMIRATES NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 244. UNITED ARAB EMIRATES NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 245. UNITED ARAB EMIRATES NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 246. UNITED ARAB EMIRATES NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 247. UNITED ARAB EMIRATES NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 248. UNITED ARAB EMIRATES NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 249. SAUDI ARABIA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 250. SAUDI ARABIA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 251. SAUDI ARABIA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 252. SAUDI ARABIA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 253. SAUDI ARABIA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2024 (USD MILLION)
TABLE 254. SAUDI ARABIA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2025-2030 (USD MILLION)
TABLE 255. SAUDI ARABIA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 256. SAUDI ARABIA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 257. SAUDI ARABIA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 258. SAUDI ARABIA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 259. SAUDI ARABIA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 260. SAUDI ARABIA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 261. SOUTH AFRICA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 262. SOUTH AFRICA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 263. SOUTH AFRICA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 264. SOUTH AFRICA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 265. SOUTH AFRICA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2024 (USD MILLION)
TABLE 266. SOUTH AFRICA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2025-2030 (USD MILLION)
TABLE 267. SOUTH AFRICA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 268. SOUTH AFRICA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 269. SOUTH AFRICA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 270. SOUTH AFRICA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 271. SOUTH AFRICA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 272. SOUTH AFRICA NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 273. DENMARK NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 274. DENMARK NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 275. DENMARK NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 276. DENMARK NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 277. DENMARK NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2024 (USD MILLION)
TABLE 278. DENMARK NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2025-2030 (USD MILLION)
TABLE 279. DENMARK NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 280. DENMARK NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 281. DENMARK NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 282. DENMARK NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 283. DENMARK NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 284. DENMARK NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 285. NETHERLANDS NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 286. NETHERLANDS NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 287. NETHERLANDS NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 288. NETHERLANDS NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 289. NETHERLANDS NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2024 (USD MILLION)
TABLE 290. NETHERLANDS NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2025-2030 (USD MILLION)
TABLE 291. NETHERLANDS NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 292. NETHERLANDS NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 293. NETHERLANDS NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 294. NETHERLANDS NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 295. NETHERLANDS NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 296. NETHERLANDS NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 297. QATAR NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 298. QATAR NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 299. QATAR NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 300. QATAR NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 301. QATAR NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2024 (USD MILLION)
TABLE 302. QATAR NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2025-2030 (USD MILLION)
TABLE 303. QATAR NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 304. QATAR NEUROLOGICAL BIOMARKERS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 305. QATAR NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 306. QATAR NEUROLOGICAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 307. QATAR NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 308. QATAR NEUROLOGICAL BIOMARKERS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 309. FINLAND NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 310. FINLAND NEUROLOGICAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 311. FINLAND NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 312. FINLAND NEUROLOGICAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 313. FINLAND NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2018-2024 (USD MILLION)
TABLE 314. FINLAND NEUROLOGICAL BIOMARKERS MARKET SIZE, BY IMAGING TECHNIQUES, 2025-2030 (USD M

Samples

Loading
LOADING...

Companies Mentioned

  • Danaher Corporation
  • Thermo Fisher Scientific Inc.
  • Roche Holding AG
  • Siemens Healthineers AG
  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • PerkinElmer, Inc.
  • Quanterix Corporation
  • Meso Scale Diagnostics, LLC
  • Fujirebio Diagnostics, Inc.

Table Information

Report AttributeDetails
No. of Pages180
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 11.74 Billion
Forecasted Market Value ( USD ) by 2030 $ 22.59 Billion
Compound Annual Growth Rate14.0%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Neurological Biomarkers Market Size, Share & Trends Analysis Report by Application (Alzheimer's, Parkinson's, Multiple Sclerosis, Autism), Type, End Use, Region, with Growth Forecasts, 2025-2030 - Product Image

Neurological Biomarkers Market Size, Share & Trends Analysis Report by Application (Alzheimer's, Parkinson's, Multiple Sclerosis, Autism), Type, End Use, Region, with Growth Forecasts, 2025-2030

  • Report
  • 120 Pages
  • Global
From
Neurological Biomarkers for Alzheimer`s and Parkinson`s Diseases - Global Strategic Business Report - Product Image

Neurological Biomarkers for Alzheimer`s and Parkinson`s Diseases - Global Strategic Business Report

  • Report
  • 196 Pages
  • Global
From
Neurological Biomarkers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Neurological Biomarkers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 181 Pages
  • Global
From
Brain Biomarkers Market by Biomarker Type (Genetic, Imaging, Metabolite), Disease Indication (Alzheimer's Disease, Epilepsy, Multiple Sclerosis), Sample Type, Technology, End User - Global Forecast 2025-2030 - Product Image

Brain Biomarkers Market by Biomarker Type (Genetic, Imaging, Metabolite), Disease Indication (Alzheimer's Disease, Epilepsy, Multiple Sclerosis), Sample Type, Technology, End User - Global Forecast 2025-2030

  • Report
  • 187 Pages
  • Global
From
Neurological Biomarkers - Global Strategic Business Report - Product Image

Neurological Biomarkers - Global Strategic Business Report

  • Report
  • 389 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.